Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
8
×
startups
8
×
life sciences
national blog main
boston blog main
boston top stories
deals
clinical trials
fda
medical device
national top stories
raleigh-durham blog main
san francisco blog main
glaxosmithkline
investing
new york blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
avexis
boston
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
detroit blog main
detroit top stories
drugs
funding
indiana blog main
indiana top stories
macrolide pharmaceuticals
national
new york top stories
nonalcoholic steatohepatitis
seattle blog main
seattle top stories
texas blog main
texas top stories
vaccines
What
disease
8
×
drug
medicines
new
therapeutics
adds
ago
companies
diseases
infectious
lung
nash
news
rare
roundup
year
years
according
address
akcea
alliance
allosteric
app
approved
areas
associated
attacks
bacteria
bio
biopharma
biosciences
biotech
bio’s
brii
building
business
called
cases
caused
centers
Language
unset
Current search:
startups
×
biotech
×
disease
×
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@techcrunch.com
5 years ago
RDMD attacks rare diseases with data mined from health records
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed